Ardent Health Q2 Net Income $17M; Adjusted EBITDA $115M; Reaffirms FY26 Guidance
Ardent Health, Inc. announced its second quarter 2026 financial results, reporting a significant decrease in net income and Adjusted EBITDA year-over-year, with net income attributable to the company falling to $17 million on $1.62 billion in revenue. Despite these declines, the company saw a 67% increase in operating cash flow to $197 million and reaffirmed its full-year 2026 Adjusted EBITDA guidance. Management noted that operational actions, including an improved payor contract and increased savings from its IMPACT program, are expected to mitigate lower volumes, though full-year net income guidance was revised downwards.
Key Highlights
- Net income attributable to Ardent Health for Q2 2026 was $17 million, down from $73 million year-over-year.
- Total revenue for Q2 2026 decreased 1.4% year-over-year to $1.62 billion.
- Adjusted EBITDA for Q2 2026 was $115 million, a 32.3% decrease year-over-year.
- Operating cash flow for Q2 2026 increased 67% year-over-year to $197 million.
- Company reaffirmed full-year 2026 Adjusted EBITDA guidance of $485 million to $535 million.
- Full-year 2026 net income guidance revised down to $110 million - $163 million from $129 million - $183 million.
- Repurchased 1.4 million shares of common stock for $13 million during Q2 2026.
- IMPACT program savings expected to generate at least $70 million in 2026, up from $55 million previously.
Price Impact
More from ARDT
Ardent Health Recharacterizes CEO Departure as 'Cause', Halts $4.5M Severance
Ardent Health Q2 Net Income Attributable to Company $16.9M, down from $73.0M
Ardent Health Finalizes Separation Agreement with Former CEO Martin Bonick